Spots Global Cancer Trial Database for Combined Breast Cancer Risk Study
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Combined Breast Cancer Risk Study
Official Title: Evaluation of a Combined Breast Cancer Risk Derived From a Polygenic Risk Score and the Tyrer-Cuzick Model
Study ID: NCT03067389
Conditions
Interventions
Study Description
Brief Summary: A prospective, non-interventional study in women 18 to 84 years of age. Subjects will provide a sample for genetic testing and information about their medical and family history. The results of the genetic test will be combined with clinical data to validate a method of predicting breast cancer risk.
Detailed Description: This is a prospective, non- interventional study. Women presenting at imaging centers for routine breast cancer screening or breast cancer diagnostic assessment and who provide written informed consent will undergo genetic testing. Subjects will also provide information about their personal medical and cancer history and family cancer history. The results of the genetic test will be combined with the subject's clinical information, family history, and a risk assessment model to validate a new method of predicting breast cancer.
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: Yes
Locations
The Breast Center of Northwest Arkansas, Fayetteville, Arkansas, United States
Bethesda Health, Boynton Beach, Florida, United States
Cuda Women's Health Center, Hyannis, Massachusetts, United States
Elizabeth Wende Breast Care, Rochester, New York, United States
Contact Details
Name: John Holmsn, MD
Affiliation: Myriad Genetics, Inc.
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
